Juvenile idiopathic arthritis - Globe Thesis

Keyword [Juvenile idiopathic arthritis] Result: 41 - 60 \| Page: 3 of 5
41.	The Study On The Pathogenesis Of NLRP3 Inflmmasome In Systemic Juvenile Idiopathic Arthritis
42.	Efficacy And Safety Of Totilizumab In Treatment Of Refractory Systemic Juvenile Idiopathic Arthritis
43.	1. Activity And Quality Of Life Assessment Of Juvenile Idiopathic Arthritis 2. Clinical Analysis Of Multiple Arteritis In Children
44.	Characterization Of Gut Microbiota In Systemic-onset Juvenile Idiopathic Arthritis
45.	Clinical Comparison Of Adult-onset Still’s Disease And Systemic Juvenile Idiopathic Arthritis
46.	Clinical Analysis Of HLA-B27-Positive Enthesitis Related Arthritis In 70 Cases
47.	Ⅰ A Retrospective Single-center Study: Clinical Analysis Of Macrophage Activation Syndrome In Pediatric Patients With Autoimmune Diseases Ⅱ The Clinical Analysis Of Kawasaki Disease Associated With Macrophage Activation Syndrome And The Diagnostic Criter
48.	Clinical Significance Of Inflammatory Cytokines In Systemic Juvenile Idiopathic Arthritis
49.	Study Of Autophagy In The Pathogenesis Of Systemic Juvenile Idiopathic Arthritis And The Effect Of Vitamin D
50.	Clinical Analysis Methods Of Joint Effusion In Children
51.	Clinical Analysis Of Systemic Juvenile Idiopathic Arthritis-associated Macrophage Activation Syndrome
52.	Clinicalanalysis Of Polyarticular Juvenile Idiopathic Arthritis In 156 Cases
53.	Adjunctive Vitamin D For Treatment Of Active Juvenile Idiopathic Arthritis:An Open-label,prospective,randomized Controlled Trial
54.	Clinical Analysis Of Polyarticular Juvenile Idiopathic Arthritis And Mid-long Term Follow-up Observation Of Non-traditional Treatment
55.	The Research Of Clinical Features Of Children Under 5 Years Old With Juvenile Idiopathic Arthritis
56.	Analysis Of Dyslipidemia And Its Influencing Factors In Children With Juvenile Idiopathic Arthritis
57.	Clinical Analysis Of Oligoarticular Juvenile Idiopathic Arthritis And Enthesitis-Related Arthritis
58.	Efficacy Observation And Long-term Management Of Tocilizumab In The Treatment Of Systemic Juvenile Idiopathic Arthritis
59.	Expression And Significance Of Serum High Mobility Group Protein Box1 In Children With Henoch-sch(?)nlein Purpura And Clinical Analysis Of Coronary Artery Lesions In Children With Systemic Juvenile Idiopathic Arthritis
60.	Comparative Efficacy And Safety Of Non-steroidal Anti-inflammatory Drugs In Patients With Juvenile Idiopathic Arthritis:A Network Meta-analysis
<<First <Prev Next> Last>> Jump to